Brief: Biomed Lublin Says Medicines Authority Approves Running Clinical Trial For Anti SARS-CoV-2 Immunoglobulin

Synthaverse SA

02/12/2020 14:21

Dec 2 (Reuters) - Biomed Lublin Wytwornia Surowic i
Szczepionek SA  BML.WA :
    * SAYS POLAND'S MEDICINES AUTHORITY APPROVES CLINICAL TRIAL
OF
ANTI SARS-COV-2 IMMUNOGLOBULIN IN COVID-19 TREATMENT
    * SAYS NON-COMMERCIAL CLINICAL TRIAL WILL BE RUN BY HOSPITAL
IN
LUBLIN

Source text for Eikon:  ID:nEM9mtZK5a 
Further company coverage:  BML.WA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))